RxDoctor Payments Data

Bridgette Franey

Family Medicine · Nashville, TNNPI 1417970831

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,019 of the $1,541 with a category attached, or 66.2%. Astrazeneca UK Limited accounts for 97.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,498 and has fallen 98.2% since, to $27 in 2023.

$1,541in general payments, 2019–2025

Across 12 payments — averaging $128.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$1K
  • Lemaitre Vascular, Inc.$27
  • Intercept Pharmaceuticals, Inc.$16
$2,038,696in research payments, 2019–2025

Across 39 payments — averaging $52,274 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1.2M
  • Pfizer$540K
  • AstraZeneca$289K

What the payments were for

  • Travel & lodging$1,01966%
  • Food & beverage$52134%

General payments by program year

19
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,541 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee →

Other family medicine in Nashville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →